Discipline

Medical Oncologist

Interests

Renal cell carcinoma (kidney), Bladder cancer, Genitourinary tumors

Biography

Dr. Toni K. Choueiri is Associate Professor of Medicine at Harvard Medical School and Attending Physician in the Division of Solid Tumor Oncology at Dana-Farber Cancer Institute (DFCI). He also serves as the co-director of the Tissue Acquisition, Pathology, and Clinical Data Core of the Kidney SPORE at Dana-Farber/Harvard Cancer Center and is the leader of the Kidney Cancer Center at DFCI and Brigham and Women's Hospital (BWH). Clinically and academically, Dr. Choueiri's efforts have largely centered on improving the care of patients with renal cell carcinoma (RCC).

Dr. Choueiri's research focuses on clinical trials with aims to improve the treatment of patients with advanced renal cell carcinoma as well as the development of novel agents for this disease. Dr. Choueiri is currently involved in collaborative efforts with basic scientists to analyze clinical, tissue, and serum biomarkers to optimize the administration of targeted therapeutic agents in renal cell carcinoma. In addition, he has also established several collaborations to characterize the side effects and risks of antiangiogenic agents used in RCC using a large scale approach, such as meta-analyses from available published trials or national databases such as the SEER database. 

Background

Board Certification
Internal Medicine, 2004
Medical Oncology, 2007

Fellowship
Cleveland Clinic Foundation, Hematology/Medical Oncology

Residency
Cleveland Clinic Foundation, Internal Medicine

Medical School
Saint Joseph University Faculte of Medicine